James D. Whaley

James D. Whaley

Auto-generated profile, based on publicly available information

James D. Whaley

Department of Orthopedic Surgery, Beaumont Health System, Royal Oak, MI, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
VSVani J. Sabesan
Vani J. Sabesan
RSRajin Shahriar
Rajin Shahriar
GPGraysen R. Petersen-Fitts
Graysen R. Petersen-Fitts
JWJames D. Whaley
James D. Whaley
TBTherese Bou-Akl
Therese Bou-Akl
MMMarc Milia
Marc Milia

20 February 2015 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
GWGuona Wang
Guona Wang
YWYi‐Chinn Weng
Yi‐Chinn Weng
XHXiqian Han
Xiqian Han
JWJames D. Whaley
James D. Whaley
KMKeith R. McCrae
Keith R. McCrae
WCWen‐Hai Chou
Wen‐Hai Chou
Thrombolysis remains the only effective therapy to reverse acute ischaemic stroke. However, delayed treatment may cause serious complications including hemorrhagic transformation and reperfusion injury. The level of lipocalin‐2 (LCN2) is elevated in the plasma of ischaemic stroke patients, but its role in stroke is unknown. Here, we show that LCN2 was acutely induced in mice after ischaemic stroke and is an important mediator of reperfusion injury. Increased levels of LCN2 were observed in mouse serum as early as 1 hr after transient middle cerebral artery occlusion (tMCAO), reaching peak levels at 23 hrs. LCN2 was also detected in neutrophils infiltrating into the ipsilateral hemisphere, as well as a subset of astrocytes after tMCAO, but not in neurons and microglia. Stroke injury, neurological deficits and infiltration of immune cells were markedly diminished in LCN2 null mice after tMCAO, but not after permanent MCAO (pMCAO). In vitro, recombinant LCN2 protein induced apoptosis in primary cultured neurons in a dose‐dependent manner. Our results demonstrate that LCN2 is a neurotoxic factor secreted rapidly in response to cerebral ischaemia, suggesting its potential usage as an early stroke biomarker and a novel therapeutic target to reduce stroke‐reperfusion injury.

1 December 2016 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
RSRyan Smith
Ryan Smith
DLDaniel J. Lombardo
Daniel J. Lombardo
GPGraysen R. Petersen-Fitts
Graysen R. Petersen-Fitts
CFCharles Frank
Charles Frank
TTTroy Tenbrunsel
Troy Tenbrunsel
VSVani J. Sabesan
Vani J. Sabesan
The published return-to-play (RTP) rates for Major League Baseball (MLB) pitchers who have undergone surgical repair of superior labrum anterior-posterior (SLAP) tears vary widely and are generally accepted to be lower in the subset of competitive throwers. The efficacy of surgical treatment for MLB players is largely unknown. To examine the RTP rate and performance of MLB pitchers who have undergone SLAP tear repair between 2003 and 2010. Descriptive epidemiological study. A retrospective review of MLB pitchers undergoing SLAP repair was performed using the MLB disabled list. Data collected included the following player statistics: earned run average (ERA), walks plus hits per inning pitched (WHIP), and innings pitched (IP). The mean values for performance variables both before and after surgery were compared. A definition of return to prior performance (RTPP) was established as an ERA within 2.00 and WHIP within 0.500 of preoperative values. Twenty-four MLB players met inclusion criteria, of which 62.5% were able to RTP at the MLB level after SLAP repair surgery. Of those able to RTP, 86.7% were able to RTPP. However, the overall rate of RTPP, including those unable to RTP, was 54.2%. Mean performance analysis of the RTP group revealed a statistically significant decrease in IP for MLB pitchers throwing a mean 101.8 innings before injury and 65.53 innings after injury (P = .004). Of those pitchers able to RTP, chances of a full recovery were good (86.7%). Our results indicate the need for future research aimed at proper surgical selection of who will return to play, as they will likely achieve full recovery. We believe this information can help surgeons advise high-level overhead-throwing athletes about expected outcomes for surgical treatment of SLAP tears.

25 January 2017 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
VSVani J. Sabesan
Vani J. Sabesan
DLDaniel Lombardo
Daniel Lombardo
GPGraysen Petersen-Fitts
Graysen Petersen-Fitts
MWMartin Weisman
Martin Weisman
KRKyle Ramthun
Kyle Ramthun
JWJames Whaley
James Whaley

1 June 2020 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MSMatthew P. Siljander
Matthew P. Siljander
JWJames D. Whaley
James D. Whaley
DKDenise M. Koueiter
Denise M. Koueiter
MAMariam Alsaleh
Mariam Alsaleh
MKMark S. Karadsheh
Mark S. Karadsheh

1 June 2017 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
VSVani J. Sabesan
Vani J. Sabesan
GPGraysen Petersen-Fitts
Graysen Petersen-Fitts
DLDaniel Lombardo
Daniel Lombardo
DBDaniel Briggs
Daniel Briggs
JWJames Whaley
James Whaley